ðĐš Acute Opioid Toxicity
1) INTRODUCTION
- Opioids
āļāļĢāļāļāļāļĨุāļĄ opiates (morphine, heroin) āđāļĨāļ°
synthetic/semi-synthetic (fentanyl, methadone, tramadol, nitazenes āļŊāļĨāļŊ)
- āļัāļāļŦāļēāļŦāļĨัāļāđāļāļัāļāļุāļัāļāđāļิāļāļāļēāļ synthetic opioids āđāļāļĒāđāļāļāļēāļ° fentanyl/fentalogs āđāļĨāļ° nitazenes
āļึ่āļāļĄี potency āļŠูāļāļĄāļēāļ
- āļāļēāļĢāđāļŠีāļĒāļีāļ§ิāļāļŠ่āļ§āļāđāļŦāļ่āđāļิāļāļāļēāļ respiratory depression → hypoxia
2) PHARMACOLOGY & TOXICOLOGY
Receptors
- Mu
(Ξ):
analgesia, euphoria, respiratory depression, miosis
- Kappa
(Κ):
dysphoria, psychotomimetic
- Delta
(Îī):
analgesia (āļĢāļāļāļĨāļāļĄāļē)
Cellular effects
- ↓ Adenylate cyclase → ↓ cAMP
- ↑ K⁺ efflux → hyperpolarization
- ↓ Ca²⁺ influx → ↓ neurotransmitter release
→ āļāļĨāļĢ่āļ§āļĄ: CNS depression + respiratory depression
Synthetic opioids
- Lipophilicity
āļŠูāļ → āđāļ้āļēāļŠāļĄāļāļāđāļĢ็āļ§ → potency āļŠูāļ
- āļัāļ§āđāļŦāļĄ่āđ āđāļ่āļ isonitazene, protonitazene, brorphine āđāļĄ่āļึ้āļ urine immunoassay
3) KINETICS āļี่āļŠāļģāļัāļāļ่āļāļāļēāļĢāļĢัāļāļĐāļē
- Vd āļŠูāļāļĄāļēāļ (1–10 L/kg) →
āđāļĄ่ dialyzable
- āļĄี active metabolite āđāļ่āļ morphine-6-glucuronide
- Half-life
āļ่āļēāļāļัāļāļĄāļēāļ āđāļ่āļ
- Heroin:
āļŠั้āļ
- Methadone:
āļĒāļēāļ§āļĄāļēāļ
- Sustained-release
→ delayed absorption
- Crushed
SR oxycodone → peak āđāļĢ็āļ§ → overdose āļĢุāļāđāļĢāļ
4) CLINICAL FEATURES
Toxidrome āļŦāļĨัāļāļāļāļ opioid
- Respiratory
depression = āļัāļ§āļ่āļāļี้āļŠāļģāļัāļāļี่āļŠุāļ
- Triad:
↓ mental status +
miosis + ↓ RR
- RR
<12/min āđāļ็āļ predictor āļี่āļีāļี่āļŠุāļāļāļāļ
opioid toxicity
āļื่āļāđ
- Hypotension
(histamine release)
- Hypothermia
- Seizure
→ tramadol,
tapentadol, meperidine
- āļāļāļ: aspiration, ARDS (āļāļāļŦāļĨัāļāđāļŦ้ naloxone
āļāļāļēāļāļŠูāļāđāļĢ็āļ§āđ)
- Pupils
āļāļēāļāļāļāļิāđāļ้āđāļ
- meperidine
- coingestant
āđāļ่āļ anticholinergic, sympathomimetic
5) DIFFERENTIAL DIAGNOSIS
- Ethanol
intoxication
- Clonidine
/ Îą2-agonists
- Benzodiazepines
- Gabapentinoids
(gabapentin/pregabalin)
- Hypoglycemia
- Neuro
emergency āđāļ่āļ stroke, sepsis, electrolyte disorder
6) LABORATORY / STUDIES
- āļāļĢāļ§āļāļุāļāļāļ: RBS (rapid serum
glucose)
- āļู coingestants āđāļ่āļ acetaminophen (āđāļāļāļĢāļี intentional overdose)
- CPK āļŦāļēāļāļŠāļāļŠัāļĒ rhabdomyolysis
- Urine
drug screen āđāļĄ่āļāļģāđāļ็āļāđāļāļĒ routine
- ECG āļŦāļēāļāđāļ้ methadone, loperamide, kratom, āļŦāļĢืāļāļĄีāļāļēāļāļēāļĢāđāļāļŠั่āļ/āđāļ็āļāļĨāļĄ
- CXR āļŦāļēāļ hypoxia āļŦāļĢืāļāđāļŠีāļĒāļāļāļāļāļิāļāļāļāļิ
7) MANAGEMENT (Key Practical Points)
A. Stabilization
- ABC
first
- Ventilation
āļŠāļģāļัāļāļี่āļŠุāļ
- āļั้āļāļัāļāļĢāļē RR ≥12/min āđāļ็āļāđāļ้āļēāļŦāļĄāļēāļĒ
B. Naloxone
1) āļ้āļēāļŦāļĒุāļāļŦāļēāļĒāđāļ / impending arrest
- āđāļŦ้āļัāļāļี 0.2–1 mg IV
- āļ้āļē cardiac arrest āđāļŦ้ ≥ 2 mg IV/IO
- āļ้āļāļ bag-valve-mask āļāļĢ้āļāļĄ O₂
āļ่āļāļāđāļŦ้āđāļื่āļāļĨāļ ARDS
2) āļĒัāļāļĄี spontaneous breathing
- āđāļĢิ่āļĄ low dose 0.04–0.05 mg IV
- Titrate
āļุāļ 2–3 āļāļēāļี
- āđāļ้āļēāļŦāļĄāļēāļĒ: adequate ventilation—not full awakening
3) āđāļĄ่āļĄี IV access
- IM /
IN / SC / IO āđāļŦ้āđāļ้ āđāļ่ titrate āļĒāļēāļāļāļ§่āļē
- āđāļĄ่āđāļāļ°āļāļģ nebulized/nasal āđāļāđāļĢāļāļāļĒāļēāļāļēāļĨ
4) Naloxone infusion
- āļāļģāļāļ§āļ: āđāļ้ 2/3 āļāļāļ total effective
dose āļ่āļāļั่āļ§āđāļĄāļ
- āļ้āļē withdrawal →
āļŦāļĒุāļ infusion
- āļ้āļēāļāļĨัāļāļĄāļēāļāļāļŦāļēāļĒāđāļ → restart āļāļĢึ่āļāđāļāļŠ
5) Avoid opioid re-dosing
- āļ้āļēāļĄี precipitated withdrawal → supportive
- āļŦ้āļēāļĄāđāļŦ้ opioids āļāļĨัāļāđāļ้āļēāđāļāđāļื่āļ "āđāļ้ withdrawal"
8) SPECIAL SCENARIOS
Buprenorphine overdose
- Potent
partial agonist, tightly bound receptors
- āļ้āļāļāļāļēāļĢ high-dose naloxone:
- āđāļĢิ่āļĄ 0.4–0.8 mg IV
- āļāļēāļāļ้āļāļāđāļŦ้āļĢāļ§āļĄāļŠูāļāļึāļ 10 mg
- āđāļŦ้ naloxone infusion āļŦāļĨัāļ reversal
Fentanyl āđāļĨāļ° fentalogs
- Potency
āļŠูāļ
- āļāļēāļāļ้āļāļ titrate naloxone āļŦāļĨāļēāļĒāļāļĢั้āļ
- āđāļ่āđāļāļĒāļĢāļ§āļĄ standard naloxone doses āļ็āļāļ āļŠāļģāļŦāļĢัāļ ventilation
Methadone
- Long
half-life + QT prolongation
- QT
>500 msec → monitor
≥24
hr
- āđāļ้ hypokalemia/hypomagnesemia
Loperamide overdose
- QRS
widening + QT prolongation →
VT/TdP
- āđāļŦ้ sodium bicarbonate 1–2 mEq/kg IV āļŦāļēāļ
QRS āļāļ§้āļēāļ
- Monitor
electrolytes
- Cardiac
toxicity āļāļēāļāļāļĒู่āļāļēāļāļŦāļĨāļēāļĒāļ§ัāļ
Tramadol, Tapentadol
- Seizure,
serotonin toxicity
- āļ้āļēāļัāļ → benzodiazepine
Nitazenes / benzimidazoles / brorphine
- Potent
→ āļāļēāļāļ้āļāļāđāļ้
naloxone āļ้āļģ
- Routine
management āđāļŦāļĄืāļāļ opioid toxicity
Kratom
- āļāļēāļāđāļิāļ QT prolongation, dysrhythmia, seizures
- Treat
as opioid toxicity + symptom-specific care
9) COMPLICATIONS
ARDS after naloxone
- āđāļิāļāļāļēāļ catecholamine surge āļŦāļĨัāļ reversal
- āļ้āļāļāļัāļāđāļāļĒāđāļ้ very low-dose naloxone āđāļĨāļ°
ventilate āļ่āļāļ
- āļāļēāļĢāļĢัāļāļĐāļē → supportive, prognosis āļี
Aspiration pneumonia / ARDS āļāļēāļ overdose
āđāļิāļĄ
- āļāļāđāļ้āļ่āļāļĒ
- CXR āļŦāļēāļāļĄี hypoxia / crackles
10) DISPOSITION
- āļŦāļēāļāđāļ้ short-acting opioid (heroin, fentanyl) āđāļĨāļ°āđāļĄ่āļĄีāļ āļēāļ§āļ°āđāļāļĢāļāļ้āļāļ:
- āļŠัāļāđāļāļ 2–3 āļั่āļ§āđāļĄāļ āļŦāļĨัāļ last naloxone dose
- āļŦāļēāļāđāļ้ long-acting opioid (methadone) āļŦāļĢืāļ:
- large
ingestion
- IN
naloxone high dose
- sustained-release
opioid
→ āļ้āļāļ observe āļāļēāļāļึ้āļ 4–24 āļั่āļ§āđāļĄāļ
11) PREVENTION OF RECURRENT OVERDOSE
- āđāļĢิ่āļĄ buprenorphine āđāļ้āļั้āļāđāļ่ ED
→ āļĨāļāļāļēāļĢāļāļēāļĒ
1 āļีāļ้āļēāļāļŦāļ้āļē
- āđāļŦ้ take-home naloxone āļุāļāļāļĢั้āļ
- Harm
reduction: peer support, next-day clinic, fentanyl test strips, clean
syringes
ð Key Takeaways
- RR
<12/min āļืāļ marker āļี่āļีāļี่āļŠุāļ
- āđāļ้āļēāļŦāļĄāļēāļĒāļืāļ “adequate ventilation” āđāļĄ่āđāļ่
full awakening
- Naloxone
āļ้āļāļ titrate āļ้āļ§āļĒ low-dose (0.04
mg) āļĒāļāđāļ§้āļāđāļ apnea
- Methadone
āđāļĨāļ° loperamide →
āļ้āļāļ monitor ECG
- āļĢāļ°āļ§ัāļ ARDS āļŦāļĨัāļ reversal āđāļāļĒāđāļāļāļēāļ°āđāļŦ้ naloxone āđāļĢ็āļ§āđāļิāļāđāļ
- āļŠāļāļŠัāļĒ nitazenes āļŦāļēāļ severe toxicity
āđāļ่ urine opioid negative
āđāļĄ่āļĄีāļāļ§āļēāļĄāļิāļāđāļŦ็āļ:
āđāļŠāļāļāļāļ§āļēāļĄāļิāļāđāļŦ็āļ